Mercury Bio, a Santa Fe, NM-based biotech company working in the area of targeted molecular drug delivery, achieved two financial milestones in the first half of August as it concluded a $2M seed funding round.

The seed round, which commenced in January of this year, was swiftly subscribed to by investors from across the nation, both corporations and individuals alike.